CGT

868개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-4 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved868 programs
CGTLimited DatastaleFundamenta Therapeutics, Ltd.Phase 1

ThisCART19 cells (ThisCART19 cells)

B Cell Malignancy · B Cell Malignancy

#BCellMalignancy#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleFundamenta Therapeutics, Ltd.Phase 1

ThisCART22 cells (ThisCART22 cells)

B-cell Malignancy · B-cell Malignancy

#B-cellMalignancy#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleFundamenta Therapeutics, Ltd.Phase 1

ThisCART7 cells (ThisCART7 cells)

T-Acute Lymphoblastic Leukemia; T-cell Non-Hodgkin Lymphoma · T-Acute Lymphoblastic Leukemia

#T-AcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleTimmune Biotech Inc.Phase 2

TriCAR-T-CD19 (TriCAR-T-CD19)

Non-hodgkin Lymphoma,B Cell · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleShanghai Unicar-Therapy Bio-med…Phase 1

Triple-targeted CAR-T Therapy (Triple-targeted CAR-T Therapy)

B-cell Lymphoma · B-cell Lymphoma

#B-cellLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Discontinued
CGTLimited DatastaleShanghai Unicar-Therapy Bio-med…Phase 2

U32 CAR-T (U32 CAR-T)

Acute Myeloid Leukaemia · Acute Myeloid Leukaemia

#AcuteMyeloidLeukaemia#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleShanghai Unicar-Therapy Bio-med…Phase 1

U87 CAR-T (U87 CAR-T)

Pancreatic Cancer; Solid Tumor, Adult · Pancreatic Cancer

#PancreaticCancer#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleThe Children's Hospital of Zhej…Phase 1

UCAR T-cell (UCAR T-cell)

Autoimmune Diseases; Systemic Lupus Erthematosus (SLE) · Autoimmune Diseases

#AutoimmuneDiseases#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleChinese PLA General HospitalPhase 2

UCART019 (UCART019)

B Cell Leukemia; B Cell Lymphoma · B Cell Leukemia

#BCellLeukemia#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleCellectis S.A.Phase 1

UCART123v1.2 (UCART123v1.2)

Relapsed/Refractory Acute Myeloid Leukemia · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleInstitut de Recherches Internat…Phase 1

UCART19 (UCART19)

B-cell Acute Lymphoblastic Leukemia · B-cell Acute Lymphoblastic Leukemia

#B-cellAcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleInstitut de Recherches Internat…Phase 1

UCART19 follow-up (UCART19 follow-up)

Advanced Lymphoid Leukemia · Advanced Lymphoid Leukemia

#AdvancedLymphoidLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleCellectis S.A.Phase 2

UCART20x22 (UCART20x22)

B-cell Non-Hodgkin Lymphoma (B-NHL) · B-cell Non-Hodgkin Lymphoma (B-NHL)

#B-cellNon-HodgkinLymphomaB-NHL#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleCellectis S.A.Phase 1

UCARTCS1A (UCARTCS1A)

Relapsed/Refractory Multiple Myeloma · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued
CGTLimited DatastaleDavid WaldPhase 1

UF-KURE-BCMA CAR T-cells (UF-KURE-BCMA CAR T-cells)

Multiple Myeloma; Multiple Myeloma in Relapse · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued
CGTLimited DatastaleDavid WaldPhase 1

UF-KURE19 CAR-T cells (UF-KURE19 CAR-T cells)

Non Hodgkin Lymphoma · Non Hodgkin Lymphoma

#NonHodgkinLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleAvenCell Europe GmbHPhase 1

UniCAR02-T-pPSMA (UniCAR02-T-pPSMA)

Prostate Cancer · PSMA

#PSMA#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued
CGTLimited DatastaleBioray LaboratoriesPhase 1

Universal BCMA-CD19 CART (Universal BCMA-CD19 CART)

Autoimmune Disease · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 1

Universal CD19-specific CAR gene-engineered T cells (Universal CD19-specific CAR gene-engineered T cells)

B Cell Malignancies · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 1

Universal CD7-specific CAR gene-engineered T cells (Universal CD7-specific CAR gene-engineered T cells)

T-cell Acute Lymphoblastic Leukemia; T-cell Acute Lymphoblastic Lymphoma · T-cell Acute Lymphoblastic Leukemia

#T-cellAcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting

40 / 44 pages

← PreviousNext →